" class="no-js "lang="en-US"> Naveen Jain Archives - Medtech Alert
Friday, March 29, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Viome Life Sciences Announces Expansion of Collaboration with GSK into New Therapeutic Interventions for Cancers and Autoimmune Diseases

Viome Life Sciences, a mission-driven systems biology company aiming to help individuals improve their health, […]

Viome Receives FDA Approval for its Unique mRNA Technology and AI Platform to Detect Cancers

Viome, a mission-driven bioscience company focused on helping individuals improve their health, today announced its […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more